Not checkedNot checked for notices yet.
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
Xiao Gao, Qingwei Wang, Ying Wang and 28 more
Nature Communications · 2020
doi:10.1038/s41467-020-17667-7 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
How the REGγ-proteasome pathway is regulated during the cell cycle or genotoxic insults remains unclear. Here, the authors show that NIP30 acts as a molecular switch to regulate the REGγ-proteasome activity and may provide an approach to combat drug-resistant tumours lacking functional p53.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.